The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare.
Many private companies offer services for collecting and storing a child’s umbilical cord blood at birth. Such a service is painless to both mother and baby, does not require much extra effort and could potentially safe the life of the baby or family member in the future.
One recent analysis by MarketWatch predicts the cord stem cell banking industry will grow to more than $4 billion in the United States by 2022.
Widecells Group PLC (LON:WDC) are leading a transformation in cord blood banking and stem cell treatment; making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants.